Nicotine modulates the immunological function of dendritic cells through peroxisome proliferator-activated receptor-γ upregulation

Cellular Immunology

Volumn 274, Issue 1-2, 2012, Pages 26-33

  Yanagita, Manabu ^a   Kobayashi, Ryohei ^a   Kojima, Yuko ^a   Mori, Kenta ^a   Murakami, Shinya ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Antigen presenting cells; Dendritic cells; Immuno modulation; Nicotine; PPAR

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; NICOTINE; NICOTINIC RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; T6 ANTIGEN; TUBOCURARINE CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TH1 CELL;

CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MONOCYTES; NICOTINE; NICOTINIC ANTAGONISTS; PHENOTYPE; PPAR GAMMA; RECEPTORS, NICOTINIC; SMOKING; TH1 CELLS; TH2 CELLS; TUBOCURARINE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84859913767     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.02.007     Document Type: Article

References (63)

1. Carbone D. Smoking and cancer. Am. J. Med. 1992, 93:13S-17S.
2. Erhardt L. Cigarette smoking: an undertreated risk factor for cardiovascular disease. Atherosclerosis 2009, 205:23-32.
3. Ryder M.I. The influence of smoking on host responses in periodontal infections. Periodontol 2007, 2000(43):267-277.
4. Brusselle G.G., Joos G.F., Bracke K.R. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011, 378:1015-1026.
5. Stämpfli M.R., Anderson G.P. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat. Rev. Immunol. 2009, 9:377-384.
6. Holt P.G., Keast D. Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriol. Rev. 1977, 41:205-216.
7. Geng Y., Savage S.M., Razani-Boroujerdi S., Sopori M.L. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J. Immunol. 1996, 156:2384-2390.
8. Maus A.D., Pereira E.F., Karachunski P.I., Horton R.M., Navaneetham D., Macklin K., Cortes W.S., Albuquerque E.X., Conti-Fine B.M. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol. Pharmacol. 1998, 54:779-788.
9. Kawashima K., Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther. 2000, 86:29-48.
10. Sekhon H.S., Jia Y., Raab R., Kuryatov A., Pankow J.F., Whitsett J.A., Lindstrom J., Spindel E.R. Prenatal nicotine increases pulmonary alpha7 nicotinic receptor expression and alters fetal lung development in monkeys. J. Clin. Invest. 1999, 103:637-647.
11. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
12. Blanchet M.R., Langlois A., Israel-Assayag E., Beaulieu M.J., Ferland C., Laviolette M., Cormier Y. Modulation of eosinophil activation in vitro by a nicotinic receptor agonist. J. Leukoc. Biol. 2007, 81:1245-1251.
13. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Al-Abed Y., Wang H., Metz C., Miller E.J., Tracey K.J., Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 2004, 10:1216-1221.
14. Hoffmann D., Adams J.D. Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers. Cancer Res. 1981, 41:4305-4308.
15. Sato T., Abe T., Nakamoto N., Tomaru Y., Koshikiya N., Nojima J., Kokabu S., Sakata Y., Kobayashi A., Yoda T. Nicotine induces cell proliferation in association with cyclin D1 up-regulation and inhibits cell differentiation in association with p53 regulation in a murine pre-osteoblastic cell line. Biochem. Biophys. Res. Commun. 2008, 377:126-130.
16. Feyerabend C., Higenbottam T., Russell M.A. Nicotine concentrations in urine and saliva of smokers and non-smokers. Br. Med. J. (Clin. Res. Ed.) 1982, 284:1002-1004.
17. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
18. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2001, 2:675-680.
19. Wynn T.A. T(H)-17: a giant step from T(H)1 and T(H)2. Nat. Immunol. 2005, 6:1069-1070.
20. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002, 2:151-161.
21. Belkaid Y., Oldenhove G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 2008, 29:362-371.
22. Rimoldi M., Chieppa M., Salucci V., Avogadri F., Sonzogni A., Sampietro G.M., Nespoli A., Viale G., Allavena P., Rescigno M. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 2005, 6:507-514.
23. Vassallo R., Tamada K., Lau J.S., Kroening P.R., Chen L. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J. Immunol. 2005, 175:2684-2691.
24. Nouri-Shirazi M., Guinet E. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 2003, 109:365-373.
25. Aicher A., Heeschen C., Mohaupt M., Cooke J.P., Zeiher A.M., Dimmeler S. Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation 2003, 107:604-611.
26. Willson T.M., Lambert M.H., Kliewer S.A. Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu. Rev. Biochem. 2001, 70:341-367.
27. Picard F., Auwerx J. PPAR(gamma) and glucose homeostasis. Annu. Rev. Nutr. 2002, 22:167-197.
28. Jiang C., Ting A.T., Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86.
29. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
30. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Red Eagle A., Vats D., Brombacher F., Ferrante A.W., Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120.
31. 4+ T cell anergy. J. Immunol. 2007, 178:2122-2131.
32. Gosset P., Charbonnier A.S., Delerive P., Fontaine J., Staels B., Pestel J., Tonnel A.B., Trottein F. Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur. J. Immunol. 2001, 31:2857-2865.
33. Szatmari I., Pap A., Ruhl R., Ma J.X., Illarionov P.A., Besra G.S., Rajnavolgyi E., Dezso B., Nagy L. PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 2006, 203:2351-2362.
34. Nencioni A., Grünebach F., Zobywlaski A., Denzlinger C., Brugger W., Brossart P. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. J. Immunol. 2002, 169:1228-1235.
35. Cernadas M., Lu J., Watts G., Brenner M.B. CD1a expression defines an interleukin-12 producing population of human dendritic cells. Clin. Exp. Immunol. 2009, 155:523-533.
36. Gogolak P., Rethi B., Szatmari I., Lanyi A., Dezso B., Nagy L., Rajnavolgyi E. Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARgamma. Blood 2007, 109:643-652.
37. Kroening P.R., Barnes T.W., Pease L., Limper A., Kita H., Vassallo R. Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways. J. Immunol. 2008, 181:1536-1547.
38. Mortaz E., Lazar Z., Koenderman L., Kraneveld A.D., Nijkamp F.P., Folkerts G. Cigarette smoke attenuates the production of cytokines by human plasmacytoid dendritic cells and enhances the release of IL-8 in response to TLR-9 stimulation. Respir. Res. 2009, 10:47.
39. Mortaz E., Kraneveld A.D., Smit J.J., Kool M., Lambrecht B.N., Kunkel S.L., Lukacs N.W., Nijkamp F.P., Folkerts G. Effect of cigarette smoke extract on dendritic cells and their impact on T-cell proliferation. PLoS ONE 2009, 4:e4946.
40. Brigl M., Brenner M.B. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 2004, 22:817-890.
41. Ito T., Inaba M., Inaba K., Toki J., Sogo S., Iguchi T., Adachi Y., Yamaguchi K., Amakawa R., Valladeau J., Saeland S., Fukuhara S., Ikehara S. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J. Immunol. 1999, 163:1409-1419.
42. Xia C.Q., Kao K.J. Heparin induces differentiation of CD1a+ dendritic cells from monocytes: phenotypic and functional characterization. J. Immunol. 2002, 168:1131-1138.
43. Castellano G., Woltman A.M., Schlagwein N., Xu W., Schena F.P., Daha M.R., van Kooten C. Immune modulation of human dendritic cells by complement. Eur. J. Immunol. 2007, 37:2803-2811.
44. Laudanski K., De A., Miller-Graziano C. Exogenous heat shock protein 27 uniquely blocks differentiation of monocytes to dendritic cells. Eur. J. Immunol. 2007, 37:2812-2824.
45. Laborde E.A., Vanzulli S., Beigier-Bompadre M., Isturiz M.A., Ruggiero R.A., Fourcade M.G., Catalan Pellet A.C., Sozzani S., Vulcano M. Immune complexes inhibit differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2007, 179:673-681.
46. Sharpe A.H., Wherry E.J., Ahmed R., Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 2007, 8:239-245.
47. Chen C., Qu Q.X., Huang J.A., Zhu Y.B., Ge Y., Wang Q., Zhang X.G. Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells. Immunobiology 2007, 212:159-165.
48. Selenko-Gebauer N., Majdic O., Szekeres A., Hofler G., Guthann E., Korthauer U., Zlabinger G., Steinberger P., Pickl W.F., Stockinger H., Knapp W., Stockl J. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 2003, 170:3637-3644.
49. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science 2000, 290:84-89.
50. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., Lederman S., Colonna M., Cortesini R., Dalla-Favera R., Suciu-Foca N. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 2002, 3:237-243.
51. Faveeuw C., Fougeray S., Angeli V., Fontaine J., Chinetti G., Gosset P., Delerive P., Maliszewski C., Capron M., Staels B., Moser M., Trottein F. Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett. 2000, 486:261-266.
52. Appel S., Mirakaj V., Bringmann A., Weck M.M., Grunebach F., Brossart P. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 2005, 106:3888-3894.
53. 4+ T cell-mediated protection against colitis. J. Immunol. 2007, 178:2940-2949.
54. Wohlfert E.A., Nichols F.C., Nevius E., Clark R.B. Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J. Immunol. 2007, 178:4129-4135.
55. Klotz L., Hucke S., Thimm D., Classen S., Gaarz A., Schultze J., Edenhofer F., Kurts C., Klockgether T., Limmer A., Knolle P., Burgdorf S. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1. J. Immunol. 2009, 183:129-136.
56. Barnes P.J. Chronic obstructive pulmonary disease. N. Engl. J. Med. 2000, 343:269-280.
57. Heeschen C., Jang J.J., Weis M., Pathak A., Kaji S., Hu R.S., Tsao P.S., Johnson F.L., Cooke J.P. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med. 2001, 7:833-839.
58. Saag K.G., Cerhan J.R., Kolluri S., Ohashi K., Hunninghake G.W., Schwartz D.A. Cigarette smoking and rheumatoid arthritis severity. Ann. Rheum. Dis. 1997, 56:463-469.
59. Mian M.F., Lauzon N.M., Stampfli M.R., Mossman K.L., Ashkar A.A. Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke. J. Leukoc. Biol. 2008, 83:774-784.
60. King T.E., Savici D., Campbell P.A. Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J. Infect. Dis. 1988, 158:1309-1316.
61. Harries A.D., Baird A., Rhodes J. Non-smoking: a feature of ulcerative colitis. Br. Med. J. (Clin. Res. Ed.) 1982, 284:706.
62. Calkins B.M. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig. Dis. Sci. 1989, 34:1841-1854.
63. Dubuquoy L., Jansson E.A., Deeb S., Rakotobe S., Karoui M., Colombel J.F., Auwerx J., Pettersson S., Desreumaux P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003, 124:1265-1276.